Sfoglia per Rivista THE JOURNAL OF INFECTIOUS DISEASES
Antiviral activity of the combination of interferon and ribavirin against chikungunya virus: are the results conclusive?
2017-01-01 Scagnolari, C; Caputo, B; Rezza, G; Antonelli, G
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: The D:A:D Study a
2013-01-01 Ryom, Lene; Mocroft, Amanda; Kirk, Ole; Worm, Signe W.; Kamara, David A.; Reiss, Peter; Ross, Michael; Fux, Christoph A.; Morlat, Philippe; Moranne, Olivier; Smith, Colette; Lundgren, Jens D; D:a:d Study, Group; Castagna, Antonella
Both Class-I and Class-III MHC genetic subregions contribute to natural long-term non progression in HIV infection
2012-01-01 Guergnon, J1; Dalmasso, C; Broet, P; Meyer, L; Westrop, Sj; Imami, N; Vicenzi, E; Morsica, G; Tinelli, M; Zanone Poma, B; Goujard, C; Potard, V; Gotch, Fm; Casoli, C; Cossarizza, A; Macciardi, F; Debré, P; Delfraissy, Jf; Galli, M; Autran, B; Costagliola, D; Poli, Guido; Theodorou, I; Riva, A; Gisheal, Consortium
CCR2-64I polymorphism, syncytium-inducing HIV strains, and disease progression
2000-01-01 Vicenzi, E.; Ghezzi, S.; Brambilla, A.; Sheppard, H. W.; Lazzarin, A.; Poli, Guido; Michael, N. L.
Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection
1999-01-01 Blasi, F; Boman, J; Esposito, G; Melissano, Germano; Chiesa, Roberto; Cosentini, R; Tarsia, P; Tshomba, Yamume; Betti, M; Alessi, M; Morelli, N; Allegra, L.
Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir
2011-01-01 Canducci, Filippo; Ceresola Elisa, R.; Boeri, Enzo; Spagnuolo, Vincenzo; Cossarini, Francesca; Castagna, Antonella; Lazzarin, Adriano; Clementi, Massimo
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients
2015-01-01 Lichtner, Miriam; Cicconi, Paola; Vita, Serena; Cozzi-Lepri, Alessandro; Galli, Massimo; Lo Caputo, Sergio; Saracino, Annalisa; De Luca, Andrea; Moioli, Mariacristina; Maggiolo, Franco; Marchetti, Giulia; Vullo, Vincenzo; D'arminio Monforte, Antonella; on behalf of the Icona Foundation Study, Group; Castagna, Antonella
Cytomegalovirus infection of the central nervous system in patients with aids: Diagnosis by DNA amplification from cerebrospinal fluid
1992-01-01 Cinque, Paola; Vago, Luca; Brytting, Maria; Castagna, Antonella; Accordini, Antonella; Sundqvist, Vivi anne; Zanchetta, Nadia; D’arminio Monforte, Antonella; Wahren, Britta; Lazzarin, Adriano; Linde, Annika
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
2014-01-01 Castagna, Antonella; Maggiolo, Franco; Penco, Giovanni; Wright, David; Mills, Anthony; Grossberg, Robert; Molina Jean, Michel; Chas, Julie; Durant, Jacques; Moreno, Santiago; Doroana, Manuela; Ait Khaled, Mounir; Huang, Jenny; Min, Sherene; Song, Ivy; Vavro, Cindy; Nichols, Garrett; Yeo Jane, M.
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: Kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange
1997-01-01 Bagnarelli, P.; Candela, M.; Valenza, A.; Manzin, A.; Solforosi, L.; Mazzola, F.; Butini, L.; Clementi, Massimo
Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug-experienced human immunodeficiency virus-infected persons with detectable virus load: A controlled study of 3 IL-2 regimens with antiviral drug therapy
2001-01-01 Tambussi, G; Ghezzi, S; Nozza, S; Vallanti, G; Magenta, L; Guffanti, M; Brambilla, A; Vicenzi, E; Carrera, P; Racca, S; Soldini, L; Gianotti, N; Murone, M; Veglia, F; Poli, Guido; Lazzarin, A.
ELEVATED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA IN ZAIRIAN NEONATE PLASMAS - IMPLICATIONS FOR PERINATAL INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
1994-01-01 Brown, Cc; Poli, Guido; Lubaki, N; Stlouis, M; Davachi, F; Musey, L; Manzila, T; Kovacs, A; Quinn, Tc; Fauci, As
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide
2003-01-01 Walmsley, S; Henry, K; Katlama, C; Nelson, M; Castagna, Antonella; Reynes, J; Clotet, B; Hui, J; Salgo, M; Demasi, R; Delehanty, J.
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients
2010-01-01 Abate, DAVIDE ANTONIO; Saldan, Alda; Fiscon, Marta; Cofano, S; Paciolla, Adriana; Furian, Lucrezia; Ekser, Burcin; Biasolo, MARIA-ANGELA; Cusinato, Riccardo; Mengoli, Carlo; Bonfante, Luciana; Rossi, Barbara; Rigotti, Paolo; Sgarabotto, Dino; Barzon, Luisa; Palu', Giorgio
Ganciclovir therapy for cytomegalovirus (cmv) infection of the central nervous system in aids patients: Monitoring by cmv dna detection in cerebrospinal fluid
1995-01-01 Cinque, Paola; Baldanti, Fausto; Vago, Luca; Terreni, Maria Rosa; Lillo, Flavia; Furione, Milena; Castagna, Antonella; Monforte, Antonella D’arminio; Lazzarin, Adriano; Linde, Annika
Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men
2003-01-01 Renzi, C.; Douglas, Jr. J. M.; Foster, M.; Critchlow, C. W.; Ashley-Morrow, R.; Buchbinder, S. P.; Koblin, B. A.; Mckirnan, D. J.; Mayer, K. H.; Celum, C. L.
Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear cells: implication for tat-mediated pathogenesis
2000-01-01 Benelli, R.; Barbero, A.; Ferrini, S.; Scapini, P.; Cassatella, M.; Bussolino, F.; Tacchetti, Carlo; Noonan, D. N.; Albini, A.
Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy
2001-01-01 Lillo, Fb; Ferrari, D; Veglia, F; Origoni, Massimo; Grasso, Ma; Lodini, S; Mastrorilli, E; Taccagni, G; Lazzarin, A; UBERTI FOPPA, Caterina
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by SDF-1 chemokine gene polymorphism analysis
1999-01-01 Balotta, C.; Bagnarelli, P.; Corvasce, S.; Mazzucchelli, R.; Colombo, M. C.; Papagno, L.; Santambrogio, S.; Ridolfo, A. L.; Violin, M.; Berlusconi, A.; Velleca, R.; Facchi, G.; Moroni, M.; Clementi, Massimo; Galli, M.
Impaired CD4(+) T-Cell Restoration in the Small Versus Large Intestine of HIV-1-Positive South Africans Receiving Combination Antiretroviral Therapy
2013-01-01 Cassol, E; Malfeld, S; Mahasha, P; Bond, R; Slavik, T; Seebregts, C; Poli, Guido; Cassol, S; van der Merwe, Sw; Rossouw, T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antiviral activity of the combination of interferon and ribavirin against chikungunya virus: are the results conclusive? | 1-gen-2017 | Scagnolari, C; Caputo, B; Rezza, G; Antonelli, G | |
| Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: The D:A:D Study a | 1-gen-2013 | Ryom, Lene; Mocroft, Amanda; Kirk, Ole; Worm, Signe W.; Kamara, David A.; Reiss, Peter; Ross, Michael; Fux, Christoph A.; Morlat, Philippe; Moranne, Olivier; Smith, Colette; Lundgren, Jens D; D:a:d Study, Group; Castagna, Antonella | |
| Both Class-I and Class-III MHC genetic subregions contribute to natural long-term non progression in HIV infection | 1-gen-2012 | Guergnon, J1; Dalmasso, C; Broet, P; Meyer, L; Westrop, Sj; Imami, N; Vicenzi, E; Morsica, G; Tinelli, M; Zanone Poma, B; Goujard, C; Potard, V; Gotch, Fm; Casoli, C; Cossarizza, A; Macciardi, F; Debré, P; Delfraissy, Jf; Galli, M; Autran, B; Costagliola, D; Poli, Guido; Theodorou, I; Riva, A; Gisheal, Consortium | |
| CCR2-64I polymorphism, syncytium-inducing HIV strains, and disease progression | 1-gen-2000 | Vicenzi, E.; Ghezzi, S.; Brambilla, A.; Sheppard, H. W.; Lazzarin, A.; Poli, Guido; Michael, N. L. | |
| Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection | 1-gen-1999 | Blasi, F; Boman, J; Esposito, G; Melissano, Germano; Chiesa, Roberto; Cosentini, R; Tarsia, P; Tshomba, Yamume; Betti, M; Alessi, M; Morelli, N; Allegra, L. | |
| Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir | 1-gen-2011 | Canducci, Filippo; Ceresola Elisa, R.; Boeri, Enzo; Spagnuolo, Vincenzo; Cossarini, Francesca; Castagna, Antonella; Lazzarin, Adriano; Clementi, Massimo | |
| Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients | 1-gen-2015 | Lichtner, Miriam; Cicconi, Paola; Vita, Serena; Cozzi-Lepri, Alessandro; Galli, Massimo; Lo Caputo, Sergio; Saracino, Annalisa; De Luca, Andrea; Moioli, Mariacristina; Maggiolo, Franco; Marchetti, Giulia; Vullo, Vincenzo; D'arminio Monforte, Antonella; on behalf of the Icona Foundation Study, Group; Castagna, Antonella | |
| Cytomegalovirus infection of the central nervous system in patients with aids: Diagnosis by DNA amplification from cerebrospinal fluid | 1-gen-1992 | Cinque, Paola; Vago, Luca; Brytting, Maria; Castagna, Antonella; Accordini, Antonella; Sundqvist, Vivi anne; Zanchetta, Nadia; D’arminio Monforte, Antonella; Wahren, Britta; Lazzarin, Adriano; Linde, Annika | |
| Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study | 1-gen-2014 | Castagna, Antonella; Maggiolo, Franco; Penco, Giovanni; Wright, David; Mills, Anthony; Grossberg, Robert; Molina Jean, Michel; Chas, Julie; Durant, Jacques; Moreno, Santiago; Doroana, Manuela; Ait Khaled, Mounir; Huang, Jenny; Min, Sherene; Song, Ivy; Vavro, Cindy; Nichols, Garrett; Yeo Jane, M. | |
| Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: Kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange | 1-gen-1997 | Bagnarelli, P.; Candela, M.; Valenza, A.; Manzin, A.; Solforosi, L.; Mazzola, F.; Butini, L.; Clementi, Massimo | |
| Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug-experienced human immunodeficiency virus-infected persons with detectable virus load: A controlled study of 3 IL-2 regimens with antiviral drug therapy | 1-gen-2001 | Tambussi, G; Ghezzi, S; Nozza, S; Vallanti, G; Magenta, L; Guffanti, M; Brambilla, A; Vicenzi, E; Carrera, P; Racca, S; Soldini, L; Gianotti, N; Murone, M; Veglia, F; Poli, Guido; Lazzarin, A. | |
| ELEVATED LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA IN ZAIRIAN NEONATE PLASMAS - IMPLICATIONS FOR PERINATAL INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS | 1-gen-1994 | Brown, Cc; Poli, Guido; Lubaki, N; Stlouis, M; Davachi, F; Musey, L; Manzila, T; Kovacs, A; Quinn, Tc; Fauci, As | |
| Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide | 1-gen-2003 | Walmsley, S; Henry, K; Katlama, C; Nelson, M; Castagna, Antonella; Reynes, J; Clotet, B; Hui, J; Salgo, M; Demasi, R; Delehanty, J. | |
| Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients | 1-gen-2010 | Abate, DAVIDE ANTONIO; Saldan, Alda; Fiscon, Marta; Cofano, S; Paciolla, Adriana; Furian, Lucrezia; Ekser, Burcin; Biasolo, MARIA-ANGELA; Cusinato, Riccardo; Mengoli, Carlo; Bonfante, Luciana; Rossi, Barbara; Rigotti, Paolo; Sgarabotto, Dino; Barzon, Luisa; Palu', Giorgio | |
| Ganciclovir therapy for cytomegalovirus (cmv) infection of the central nervous system in aids patients: Monitoring by cmv dna detection in cerebrospinal fluid | 1-gen-1995 | Cinque, Paola; Baldanti, Fausto; Vago, Luca; Terreni, Maria Rosa; Lillo, Flavia; Furione, Milena; Castagna, Antonella; Monforte, Antonella D’arminio; Lazzarin, Adriano; Linde, Annika | |
| Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men | 1-gen-2003 | Renzi, C.; Douglas, Jr. J. M.; Foster, M.; Critchlow, C. W.; Ashley-Morrow, R.; Buchbinder, S. P.; Koblin, B. A.; Mckirnan, D. J.; Mayer, K. H.; Celum, C. L. | |
| Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear cells: implication for tat-mediated pathogenesis | 1-gen-2000 | Benelli, R.; Barbero, A.; Ferrini, S.; Scapini, P.; Cassatella, M.; Bussolino, F.; Tacchetti, Carlo; Noonan, D. N.; Albini, A. | |
| Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy | 1-gen-2001 | Lillo, Fb; Ferrari, D; Veglia, F; Origoni, Massimo; Grasso, Ma; Lodini, S; Mastrorilli, E; Taccagni, G; Lazzarin, A; UBERTI FOPPA, Caterina | |
| Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by SDF-1 chemokine gene polymorphism analysis | 1-gen-1999 | Balotta, C.; Bagnarelli, P.; Corvasce, S.; Mazzucchelli, R.; Colombo, M. C.; Papagno, L.; Santambrogio, S.; Ridolfo, A. L.; Violin, M.; Berlusconi, A.; Velleca, R.; Facchi, G.; Moroni, M.; Clementi, Massimo; Galli, M. | |
| Impaired CD4(+) T-Cell Restoration in the Small Versus Large Intestine of HIV-1-Positive South Africans Receiving Combination Antiretroviral Therapy | 1-gen-2013 | Cassol, E; Malfeld, S; Mahasha, P; Bond, R; Slavik, T; Seebregts, C; Poli, Guido; Cassol, S; van der Merwe, Sw; Rossouw, T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile